NasdaqCM - Delayed Quote USD

Kronos Bio, Inc. (KRON)

0.6750
+0.0035
+(0.52%)
At close: May 30 at 4:00:02 PM EDT
0.6605
-0.01
(-2.15%)
After hours: May 30 at 5:37:16 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
9,192
9,848
6,288
0
0
Operating Expense
59,790
73,280
123,489
137,115
151,398
Operating Income
-50,598
-63,432
-117,201
-137,115
-151,398
Net Non Operating Interest Income Expense
5,850
6,808
9,404
3,911
320
Other Income Expense
-19,737
-29,455
-4,876
--
--
Pretax Income
-64,485
-86,079
-112,673
-133,204
-151,078
Net Income Common Stockholders
-64,485
-86,079
-112,673
-133,204
-151,078
Diluted NI Available to Com Stockholders
-64,485
-86,079
-112,673
-133,204
-151,078
Basic EPS
-1.07
--
-1.95
-2.37
-2.76
Diluted EPS
-1.07
--
-1.95
-2.37
-2.76
Basic Average Shares
60,391.5000
--
57,744
56,201.3980
54,753.5990
Diluted Average Shares
60,391.5000
--
57,744
56,201.3980
54,753.5990
Total Operating Income as Reported
-70,335
-92,887
-122,077
-137,115
-151,398
Total Expenses
59,790
73,280
123,489
137,115
151,398
Net Income from Continuing & Discontinued Operation
-64,485
-86,079
-112,673
-133,204
-151,078
Normalized Income
-44,748
-56,624
-107,797
-133,204
-151,078
Interest Income
5,850
6,808
9,404
3,911
320
Interest Expense
--
--
--
--
0
Net Interest Income
5,850
6,808
9,404
3,911
320
EBIT
-50,598
-63,432
-117,201
-137,115
-151,398
EBITDA
-49,137
-61,716
-115,065
-134,849
-149,421
Reconciled Depreciation
1,461
1,716
2,136
2,266
1,977
Net Income from Continuing Operation Net Minority Interest
-64,485
-86,079
-112,673
-133,204
-151,078
Total Unusual Items Excluding Goodwill
-19,737
-29,455
-4,876
--
--
Total Unusual Items
-19,737
-29,455
-4,876
--
--
Normalized EBITDA
-29,400
-32,261
-110,189
-134,849
-149,421
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 10/9/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

IPSC Century Therapeutics, Inc.
0.5304
-4.78%
 
EPIX ESSA Pharma Inc.
1.6800
+0.60%
 
PMVP PMV Pharmaceuticals, Inc.
0.8782
-1.92%
 
LYEL Lyell Immunopharma, Inc.
0.4367
+8.74%
 
NXTC NextCure, Inc.
0.4924
-0.85%
 
ANTX AN2 Therapeutics, Inc.
1.0600
-12.40%
 
IKNA Ikena Oncology, Inc.
1.1900
+0.85%
 
SYBX Synlogic, Inc.
1.1500
0.00%
 
BOLT Bolt Biotherapeutics, Inc.
0.3146
+0.19%
 
LVTX LAVA Therapeutics N.V.
1.3100
-0.76%